0


通过基因组测序和数据交换发现疾病基因:基因诊断和药物开发的前景

Disease gene discovery through genome sequencing and data exchange: perspectives for genetic diagnosis and drug development
课程网址: http://videolectures.net/mdo2014_ropers_sequencing_techniques/  
主讲教师: Hans-Hilger Ropers
开课单位: 马克斯普朗克研究所
开课时间: 2014-07-21
课程语种: 英语
中文简介:
在20世纪90年代早期,基因组研究已经转移到常见疾病上,这是由一个直观但未经证实的假设驱动的,即对于常见疾病,必须存在共同的遗传风险因素。今天,经过近二十年的全基因组关联研究(GWAS),人们一致认为常见病-常见变异假说并不适用于绝大多数常见疾病。虽然GWAS社区正在进一步扩大队列规模,以包括罕见疾病相关的变异,但其他人正在用高通量测序(HTS)取代这种方法,以寻找常见疾病病因中的重要遗传因素。然而,鉴于常见疾病的巨大遗传异质性,这两种策略都不能保证成功。因此,单基因疾病再次成为基因组研究的热点,也是因为HTS技术极大地促进了它们的分子阐明。此外,与疾病相关的标志物相反,致病突变往往提供了对潜在致病机制的直接见解。单基因疾病大多是严重的;对他们中的大多数人来说,根本的缺陷仍然是未知的,总体来说,他们并不罕见。对于早发性智力残疾(ID)和相关疾病来说,这当然是正确的,这是转诊到遗传服务机构的最常见原因,也是全世界最昂贵的诊断之一。并对其进行了深入细致的遗传学研究,从而为疾病的诊断和预防提供了依据。全基因组测序作为第一线诊断试验的引入,有望在这一领域取得进一步进展,这不仅将彻底改变遗传保健,而且将使人们对人类基因和整个人类基因组的功能有更多的了解。
课程简介: During the early 1990ies, genome research has shifted to common diseases, driven by the intuitive but unproven hypothesis that for common disorders, common genetic risk factors must exist. Today, after almost two decades of genome-wide association studies (GWAS), there is consensus that the Common Disease-Common Variant hypothesis does not apply to the vast majority of common disorders. While the GWAS community is scaling up cohort sizes even further to include rare disease associated variants, others are replacing this approach by high-throughput sequencing (HTS) in their quest for important genetic factors in the etiology of common disorders. Given the enormous genetic heterogeneity of common disorders, however, there is no guarantee for the success of either of these strategies. Therefore, single gene disorders have re-emerged as a hot topic in genome research, also because HTS techniques have greatly facilitated their molecular elucidation. Moreover, contrary to disease associated markers, disease-causing mutations often provide direct insights into the underlying pathogenic mechanisms. Single gene disorders are mostly severe; for most of them, the fundamental defect is still unknown, and collectively, they are not at all rare. This is certainly true for early onset intellectual disability (ID) and related disorders, the most common reason for referral to genetic services and one of most costly diagnoses worldwide. Genetic and molecular studies have dissected ID into many hundred distinct genetic entities, thereby providing the basis for their diagnosis, prevention and even therapy. Further progress in this field can be expected from the introduction of whole-genome sequencing as a first-line diagnostic test, which will not only revolutionize genetic health care but will also shed more light on the function of human genes and the human genome as a whole.
关 键 词: 基因诊断; 药物开发; 遗传危险
课程来源: 视频讲座网
数据采集: 2020-12-29:yxd
最后编审: 2020-12-29:yxd
阅读次数: 39